Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
Endocrinology and Metabolism
; : 830-837, 2020.
Article
en En
| WPRIM
| ID: wpr-898156
Biblioteca responsable:
WPRO
ABSTRACT
Background@#The clinical outcomes of delayed radioiodine remnant ablation (RRA) therapy in patients with low-risk papillary thyroid carcinoma (PTC) are unclear. We aimed to evaluate the clinical impact of the interval between total thyroidectomy (TT) and RRA therapy in patients with low-risk PTC. @*Methods@#We included 526 patients who underwent TT and RRA for low-risk PTC with a primary tumor size of >1 cm between 2000 and 2012. Patients were divided into the early (3 months after TT considering other prognostic factors.
Texto completo:
1
Base de datos:
WPRIM
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
Idioma:
En
Revista:
Endocrinology and Metabolism
Año:
2020
Tipo del documento:
Article